2016
DOI: 10.1016/s1773-035x(16)30013-2
|View full text |Cite
|
Sign up to set email alerts
|

Les biomarqueurs circulants du cancer : avantages et perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…As a result, EpCAM cannot be considered as a universal marker for CTC detection . In recent years, numerous marker‐free CTC enrichment methodologies based on physical properties such as density, size, deformability, and electric charge have been established to eliminate the variability of the biomarkers associated with tumor heterogeneity . Although density gradient centrifugation is cost effective, CTC loss is possible due to the unwanted migration of CTCs into the plasma .…”
Section: Introductionmentioning
confidence: 99%
“…As a result, EpCAM cannot be considered as a universal marker for CTC detection . In recent years, numerous marker‐free CTC enrichment methodologies based on physical properties such as density, size, deformability, and electric charge have been established to eliminate the variability of the biomarkers associated with tumor heterogeneity . Although density gradient centrifugation is cost effective, CTC loss is possible due to the unwanted migration of CTCs into the plasma .…”
Section: Introductionmentioning
confidence: 99%